Items

reuters.com

MOSCOW (Reuters) - Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.

The results of the two trials, conducted in June-July this year and involving 76 participants, showed 100% of participants developing antibodies to the new coronavirus and no serious side effects, The Lancet said.

Submitted by mo2 on Sat, 09/05/2020 - 04:37
cbsnews.com

The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn't need any special computer equipment to get results.

The 15-minute BinaxNOW test from Abbott Laboratories will sell for $5, giving it a competitive edge over similar tests that need to be popped into a small machine. The self-contained test is the size of a credit card and is based on the same technology used to test for the flu, strep throat and other infections.

Submitted by mo2 on Fri, 08/28/2020 - 03:00
wsj.com

As U.S. and other governments sign deals for vaccine supplies, Gates, Gavi and Serum Institute of India pledge cheap shots for developing world

The Bill & Melinda Gates Foundation said it is backing the world’s largest vaccine maker, Serum Institute of India, to churn out 100 million doses of coronavirus vaccine for poorer countries and price them at less than $3.

Submitted by mo2 on Fri, 08/07/2020 - 18:12
cnbc.com
  • White House coronavirus advisor Dr. Anthony Fauci said Monday he is "not particularly concerned" about the safety risk of a potential coronavirus vaccine by Moderna, despite the fact that it uses new technology to fight the virus. 
  • The vaccine, which entered a large phase-three human trial Monday, uses messenger ribonucleic acid, or mRNA molecules, to provoke an immune response to fight the virus.
Submitted by mo2 on Mon, 07/27/2020 - 20:58
cnn.com

(CNN) A Covid-19 vaccine likely won't be "widely available" in the US until "several months" into next year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said Friday.

"I think as we get into 2021, several months in, that you would have [a] vaccine that would be widely available to people in the United States," Fauci told the Washington Post's Bob Costa during a Post Live event.

Submitted by mo2 on Fri, 07/24/2020 - 20:33
politico.com

The United States on Tuesday recorded more than 1,000 daily deaths from the coronavirus for the first time since May, another grim sign the country is struggling to contain the pandemic six months after it emerged in the U.S.

The daily death toll from Covid-19 had been falling steadily for months after peaking at over 2,000 in mid-April, but deaths began trending upward again earlier this month as the virus stormed across the South and Southwest.

Submitted by mo2 on Fri, 07/24/2020 - 20:23